Hippocrates of Cos was one of the first who described spontaneous subarachnoid haemorrhage without special knowledge about neuro-anatomy or neuro-physiology. This haemorrhage represented a life ending event of fate for him. Inventions like computed tomography or angiography gave better insight into the patterns of this life threatening disease. Progress in management was developed by new cranial approaches, new generations of clips and better intensive care modalities. The latter could be represented by the increasing use of nimodipine or the integration of the early sealing mode of an intracranial aneurysm after rupture within 72 hours. Endovascular therapies revolutionised aneurysm management, strengthening the interdisciplinary team-work of neuroradiologists, anesthesists and neurosurgeons. These changes in the past lead to a significant reduction in mortality, producing more survivors who suffer different stages of morbidity. Morbidity in this context is represented by physical handicaps and dependencies, but also mental, emotional and cognitive impairments. However, there are still some challenges to manage, like the cerebral vasospasm or delayed cerebral ischemia including spreading depolarisations, (prolonged) hydrocephalus, and cognitive long-term morbidity that may complicate a smooth and easy reintegration into daily life. Nevertheless, dealing with this long history and the aforementioned challenges, there is still the opinion that there is stagnation in the progress within this field of study. Scientists lack new ideas for surgical procedures or clips, endovascular devices do not always represent safe options, and medication providing protection for vasospasms still remains unknown. This book provides basic knowledge concerning this interesting disease pattern and introduces more intensive work in the field. It is written by a team of individuals from multiple disciplines that represent different parts of therapy management. The literature used is recent and promotes intensive private or independent study. The intended audiences for this book include students, residents, registrars, assistant physicians, and all physicians from neighbouring disciplines.

Linked by Blood: Hemophilia and AIDS recounts the factors responsible for the widespread infection of people with hemophilia by Human Immunodeficiency Virus (HIV)-contaminated blood and offers a prescription for addressing the challenges of future viral epidemics. The book describes the impact of AIDS on people with hemophilia, their families, and caregivers. The collection, processing, and distribution of blood in the early years of the HIV epidemic are described, including the failure of regulatory agencies to promulgate effective rules to safeguard the blood supply. The contributions of individuals and organizations that mitigated the epidemic are recognized. Linked by Blood presents recommendations for addressing the myriad medical, social, and economic challenges posed by blood-borne viral infections (AIDS, Ebola, MERS) that periodically sweep through large segments of our population.

Concise Guide to Hematology is highly practical, user-friendly, and will be invaluable to all residents, fellows, and trainees working with hematology patients. Designed to highlight the important basic concepts and diseases throughout the spectrum of hematology, the book has a clear and accessible format and includes simple line figures, algorithms, and key points thoughout. Each chapter begins with an overview and then main concepts are outlined for each disorder and topic covered. Edited by two leading figures in the rapidly evolving field of hematology, this attractively-produced and concise book is an essential guide and ready resource for all those undertaking rotations and examinations in the discipline.

Anaemia, or lack of red blood cells, is common, and can be a symptom of a serious underlying disorder. It has a number of causes, and this book stresses that it's vital to find and treat these, rather than simply prescribing iron tablets. Iron tablets do have their place in treatment, but this is rarely the full answer and priority must be given to discovering the underlying cause.

Hyperglycemia is the central metabolic abnormality in diabetes mellitus and it serves as the basis for making the diagnosis in both type 1 and type 2 diabetes. In this book, the authors present topical research in the study of the causes, symptoms and treatment options for hyperglycemia. Topics discussed include the ethiopathogenesis of stress hyperglycemia and its observation in acute coronary syndrome (ACS); developmental programming of hyperglycemia and metabolic outcomes; the role of hyperglycemia in diabetic nephropathy; and management of hyperglycemia in diabetic vascular disease.

Hemostasis (coagulation and fibrinolysis) is of importance in a broad range of medical disciplines. A high-quality hemostasis diagnosis enables a good therapy, which can be rather complicated without laboratory help. This yearbook gathers important contributions in this field and presents them in a coherent and logical format.

An apoprotein a protein that is normally attached to second molecule that is not a polypeptide, from which it has become disassociated. For example: ferritin that lacks the ferric hydroxide core could be called apoferritin. Lipid supply is a determinant of apoprotein synthesis and secretion, and cholesterol may be of particular importance in initiating apoprotein synthesis. This book presents the latest research results in this field from around the globe.

In malaria endemic areas, red cell polymorphisms that confer protection against acute uncomplicated malaria, severe malaria, and malaria mortality are widespread. However, the mode of selection favouring the red cell disorders and the precise mechanism of malaria protection remains unknown. In this book, the authors describe possible mechanisms by which the red cell disorders might confer resistance or susceptibility to human Plasmodium. This book shows how the interactions between Plasmodium species appear more evident through natural host protection or susceptibility and offer a good opportunity to better knowledge on this subject poorly understood. The authors have evaluated the consequences in vaccines development.

This book presents recent and important research on Chronic lymphocytic leukemia (or "chronic lymphoid leukemia"), known for short as CLL, which is a type of leukemia in which too many lymphocytes are produced. Although the malignant lymphocytes in CLL may look normal and mature, they are not and these cells may not cope effectively with infection. CLL is the most common form of leukemia in adults. Men are twice as likely to develop CLL as women. However, the key risk factor is age; over 75% of new cases are diagnosed in patients over age 50.

Anaemia is the common health problem all over the world. The term "tropical anaemia" means the anaemic disorders, which are predominant in the tropical region of the world. The purpose of this book is to summarise and present the topics specifically relating to the anaemia in the forms that is unique in the tropical countries. Due to the globalisation in the present day, the change in the epidemiology of diseases from one site to the others all around the world can be expected. The summative on the common anaemic problems in the tropical countries can be and should be performed. This book can make them at least realise the problems. The details of this book focus on the anaemia in the aspects relating to the tropical medicine. The book covers specifically the clinical aspects, scientific laboratory aspects, public health aspects as well as the social sciences relating to anaemia in important tropical diseases. The common tropical diseases, including inherited disorders and infectious diseases, which relate to the anaemia are summarised, presented and discussed. Mainly the book presents summative data from the molecular to the population scales, as well as additional metanalysis for important topics. In addition, the diagnostic guideline and clinical practice guideline of the mentioned conditions are presented.

The objective of this book is to review specific haematologic disorders that commonly present in the new-born period. It summarises and presents the topics specifically relating to the haematological disorders in neonates.

Although blood transfusion saves lives and reduces the rate of morbidity in many clinical diseases and conditions, it is associated with certain risks. A transfusion-related adverse event, also called transfusion reaction, is any unfavourable event occurring in a patient during or after blood transfusion. About 0.5 per cent to 3 per cent of all transfusions result in some adverse events, but the majority of them are minor reactions with no significant consequences. In general, transfusion-related adverse events are categorised as infectious and non-infectious. However, there are other classifications in the literature based on time of occurrence (i.e. acute versus delayed) or physiological mechanism (i.e. immune mediated versus non-immune mediated). A significant proportion of adverse events may occur as a result of errors in preparation, ordering or administration of blood and blood products. The book contains the latest research in this essential field, which has been revolutionised in recent decades.

Why is blood red? Because it contains Haemoglobin -- the most important molecule in the human body. In health -- the average person has 4 lbs. of haemoglobin and manufactures seven billion molecules of haemoglobin every second. It carries oxygen from the lungs to the cells and helps the body remove waste carbon dioxide. In sickness -- an estimated one billion people around the world have some disorder related to haemoglobin: sickle-cell anaemia, pernicious anaemias, iron-deficiency anaemia, porphyries, haemoglobin E disease, alpha-thalassemia, beta-thalassemia, and G6PD deficiency. One type of haemoglobin can be used to monitor diabetes. This basic introduction to haemoglobin includes information on the reselection of Richard Nixon, the madness of King George III, werewolves, lead poisoning, legends about Pythagoras, genetics and genetic screening, diabetes, respiration, the production of red cells, and translation of the DNA code. Haemoglobin is a fascinating molecule that touches our lives, our politics, our myths and our history. This new book presents current analyses of one of the most controversial issues of our times -- affirmative action. Proponents on both sides of the issue claim clear-cut evidence for the rightness of their arguments, yet evidence is hazy at best. This volume helps shed light on the underlying basis for affirmative action and elucidates the latest legal and social developments.

Understanding the causes of anemia is critical to inform appropriate strategies to prevent and treat anemia, particularly to reduce the risk of anemia and the burden of disease. The strength of this book lies in its cross-disciplinary nature. This publication summarizes the current state of evidence on the multifactorial causes of anemia, with a specific focus on nutritional anemia. The chapter authors are leading experts in nutrition and global health. The introductory chapters provide an overview of the global burden of anemia prevalence, the economic implications and functional consequences of anemia, and the significance of these factors to guide policy and programs. Subsequent chapters provide current evidence on iron and other micronutrient metabolism and homeostasis in regards to anemia, the multifactorial contributors to anemia (e.g. infection and genetics), and the interactions between nutrients that may contribute to anemia. The summarizing chapters detail program and policy approaches to treat, prevent and reduce anemia in the global context. Nutritional Anemia is a comprehensive resource for those involved in global health and nutrition policy, strategy, programming, or research, and serves as a guide for how government, NGO, and international agencies can effectively treat, prevent and reduce anemia globally.

Biomedical scientists are the foundation of modern healthcare, from cancer screening to diagnosing HIV, from blood transfusion for surgery to food poisoning and infection control. Without biomedical scientists, the diagnosis of disease, the evaluation of the effectiveness of treatment, and research into the causes and cures of disease would not be possible. The Fundamentals of Biomedical Science series has been written to reflect the challenges of practicing biomedical science today. It draws together essential basic science with insights into laboratory practice to show how an understanding of the biology of disease is coupled to the analytical approaches that lead to diagnosis. Assuming only a minimum of prior knowledge, the series reviews the full range of disciplines to which a Biomedical Scientist may be exposed-from microbiology to cytopathology to transfusion science. The science of transfusion and transplantation demands a multifaceted understanding of immunology, haematology, and genetics from the biomedical scientist. Transfusion and Transplantation Science synthesizes the essential concepts of these subjects and presents them within the practical framework of the hospital banking and transplantation centre, providing you with the knowledge and skills to specialize in this discipline.

The Human Genome Project has spawned a Renaissance of research faced with the daunting expectation of personalized medicine for individuals with sickle cell disease in the Genome Era. This book offers a comprehensive and timeless account of emerging concepts in clinical and basic science research, and community concerns of health disparity to educate professionals, students and the general public about meeting this challenging expectation. Contributions from physicians, research scientists, scientific administrators and community workers make Renaissance of Sickle Cell Disease Research in the Genome Era unique among the catalogue of books on this genetic disorder.Part 1 offers detailed review of the National Heart Lung and Blood Institute's leadership role in funding sickle cell research, as well as developing progressive research initiatives and the predicted impact of the Human Genome Project. Part 2 gives an account of several clinical research perspectives based on the Cooperative Study of Sickle Cell Disease. These include recommendations for newborn screening, pain management, stroke, transfusion therapy and pediatric and adult healthcare. Part 3 offers novel insights into basic science research progress and the impact of the Human Genome Project on the direction of hemoglobinopathy research, including hemoglobin switching, bone marrow transplantation and gene therapy. Part 4 engages the reader in a culture-based discussion of the stigma attached to sickle cell disease in the African American community and the apprehensions about genetic research in this community. It concludes with a global perspective on sickle cell disease from African, European and American experiences. For readers seeking a definitive account of sickle cell disease appropriate for students, researchers and community workers, this collaborative effort is an ideal textbook.

This book provides an updated overview of eicosanoid metabolism. It also presents a timely discussion of eicosanoid metabolism in the process of tumor cell metastasis, in chemoprotection and radioprotection associated with cancer therapy, and in cell differentiation. The book focuses on the role of eicosanoids in the immunology of malignant disease. This includes how various immune cell populations in cancer are affected by the secretion and action of various eicosanoids and metabolites of eicosanoids and how these processes may be affected by various pharmacological manipulations and interventions to augment anti-tumor immunity. Head and neck cancer is covered in great detail to illustrate a cancer in humans where these considerations are particularly relevant. This important volume demonstrates that the principal factor in cancer patient immunologic deficiency is related to excess secretion by monocytes of prostaglandins.

his book provides a comprehensive summary of data from basic research on characterization, regulation, and function of heme oxygenase in mammalian systems. The book also includes a major section that covers the currently used clinical methods to suppress neonatal jaundice with emphasis on the newly developed use of synthetic metalloporophyrins. This book will be welcomed by researchers and students in pharmacology, biochemistry, pharmacy, neonatology, hematology, internal medicine, and endocrinology.

Dieses Buch gibt dem Labor- und Verwaltungsleiter im Bereich der Labororganisation fur die Personalbedarfsberechnung, die Kostenstellenrechnung und Kosten-Nutzen-Beurteilung und die Fuhrung einer Laborstatistik wertvolle Hilfestellung und Anregung. Die 3., verbesserte und erweiterte Neuauflage des erstmals 1976 als Band 1 der INSTAND-Schriftenreihe erschienenen Buches enthalt zusatzlich ein Kapitel zur Kostenermittlung und - aus aktuellem Anlass - ein neues Kapitel uber deskriptive Laborstatistik. Das Buch fasst somit alle bekannten Verfahren zur Personalbedarfsberechnung und zur Kostenermittlung im Medizinischen Laboratorium zusammen und ist als Anleitung zur selbstandigen Durchfuhrung dieser Berechnungen gedacht. Das Buch will ausreichend Hilfe und Anregung geben, Probleme der Laborleitung im Bereich Organisation, Laborstatistik, Personalbedarfsberechung, Kostenstellenrechnung und Kosten-Nutzen-Analysen zu losen."

This book is a completely revised new edition of the definitive reference on disorders of hemoglobin. Authored by world-renowned experts, the book focuses on basic science aspects and clinical features of hemoglobinopathies, covering diagnosis, treatment, and future applications of current research. While the second edition continues to address the important molecular, cellular, and genetic components, coverage of clinical issues has been significantly expanded, and there is more practical emphasis on diagnosis and management throughout. The book opens with a review of the scientific underpinnings. Pathophysiology of common hemoglobin disorders is discussed next in an entirely new section devoted to vascular biology, the erythrocyte membrane, nitric oxide biology, and hemolysis. Four sections deal with and thalassemia, sickle cell disease, and related conditions, followed by special topics. The second edition concludes with current and developing approaches to treatment, incorporating new agents for iron chelation, methods to induce fetal hemoglobin production, novel treatment approaches, stem cell transplantation, and progress in gene therapy.

A cross between a dictionary and an encyclopedia, Desk Reference for Hematology, Second Edition presents a concise yet thorough examination of hematology and its relationship with other systems and disorders. The 1500 alphabetically listed articles provide quick and easy access to expert information, the 150 tables put precise data at your fingertips, and the 100 figures are a visual tool that clarify the text. The book also includes 500 references on state-of-the-art guidelines and recent developments. See what's new in the Second Edition: * Revised articles emphasizing genetics, physiology, pathological mechanisms * Updated coverage of treatments for leukemia, lymphoma, coagulation, and thrombotic disorders * Hundreds of completely new articles, new illustrations, and new explanatory diagrams as well as revised tables Completely revised, this edition covers hematopoiesis, red blood cells, granulocytes, lymphocytes, platelets and hemostasis where the respective physiology is described anemias, leukemias, lymphomas, auto-immune disorders, hemorrhagic disorders, and thrombosis where etiology, pathogenesis, diagnosis and treatment is described. The book includes coverage of blood groups and the practice of blood component therapy. The editor pays particular attention to recent developments in hematological molecular genetics and leukemogenesis. The information is cross-referenced with words highlighted in bold face within an article to indicate that further information on the subject is available under the emboldened heading. A separate table provides common abbreviations used widely throughout the text. Carefully designed for ease of use, the book provides speedy access to authoritative information on the scientific basis of blood disorders and their treatment.

Depuis sa premiere edition en 1983, il y a plus de vingt ans, le Manuel de securite biologique en laboratoire a donne des conseils pratiques sur les techniques de securite a appliquer dans les laboratoires a tous les niveaux. La bonne application des techniques microbiologiques et l'utilisation de l'equipement de securite biologique par du personnel bien entraine restent les piliers de la securite en laboratoire. Toutefois, la mondialisation, les progres technologiques, l'apparition de nouvelles maladies et les graves menaces liees a une utilisation ou a une mise en circulation deliberees de micro-organismes ou de toxines ont impose de revoir les procedures. Pour cette nouvelle edition, le manuel a donc ete considerablement revu et developpe.Le manuel couvre desormais aussi l'evaluation du risque et l'utilisation sans risque des techniques faisant appel a l'ADN recombinant. Il donne par ailleurs des lignes directrices pour la mise en service et la certification des laboratoires. Il presente les concepts de la securite biologique et les reglementations internationales les plus recentes sur le transport des matieres infectieuses. On y a egalement integre les informations sur la securite dans les laboratoires d'analyses medicales, publiees auparavant dans d'autres documents de l'OMS. Nous esperons que le manuel continuera d'inciter les pays a instituer des programmes de securite biologique et des codes nationaux de bonnes pratiques pour manipuler sans danger les matieres potentiellement infectieuses."

This book examines in detail the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the management appropriate in special clinical circumstances, including in the elderly, pregnant women, and those with lymphocyte-predominant disease. Careful attention is devoted to the emerging individually tailored treatment strategies that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The second edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by the key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.